Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wafer-level burn-in may be Aehr Test Systems’ technical edge, yet investors often just want to know who is buying stock, how margins move, or whether new EV design wins are material. That information is scattered across hundreds of pages and several form types—especially when you search for “Aehr Test Systems SEC filings explained simply.” The same hunt includes the “Aehr Test Systems quarterly earnings report 10-Q filing” and “Aehr Test Systems insider trading Form 4 transactions,” turning routine research into a time drain.
Stock Titan’s platform removes that friction. Our AI-powered summaries break down every section of the annual report—search “Aehr Test Systems annual report 10-K simplified” and jump straight to key risk factors. Receive real-time alerts for “Aehr Test Systems Form 4 insider transactions real-time,” so you see executive stock moves minutes after they hit EDGAR. New design-win announcements? We flag them the moment the company files an 8-K, giving you “Aehr Test Systems 8-K material events explained” in plain English.
Whether you’re comparing backlog growth across quarters or vetting “Aehr Test Systems executive stock transactions Form 4,” our coverage spans every disclosure type:
- AI-generated “Aehr Test Systems earnings report filing analysis” with side-by-side trend charts
- Guided walkthroughs for “understanding Aehr Test Systems SEC documents with AI”
- Red-lined changes in the preliminary “Aehr Test Systems proxy statement executive compensation” so pay packages are clear
No more digging through PDFs—our expert analysis, real-time updates, and full Form library put the critical data points in context, letting you act before the market does.
Aehr Test Systems filed a Form S-8 to register 2,500,000 shares of common stock for its 2023 Equity Incentive Plan and 300,000 shares for its Amended and Restated 2006 Employee Stock Purchase Plan.
The additional shares follow stockholder-approved plan amendments on October 20, 2025 at the company’s 2025 Annual Meeting of Stockholders. The filing incorporates prior S-8 registrations by reference and states that sales will occur as awards under the plans are exercised and/or vest.
Aehr Test Systems reported that stockholders approved amendments to two compensation plans at the company’s 2025 annual stockholders’ meeting held on October 20, 2025. The approvals cover the Amendment to the Amended and Restated 2006 Employee Stock Purchase Plan and the Amendment to the 2023 Equity Incentive Plan.
The company states that the terms of these amendments are set forth in the proxy statement dated September 10, 2025, which is incorporated by reference. The full texts of the amendments were filed as exhibits 10.1 and 10.2. This update was disclosed under Item 5.02 of an 8-K.
Aehr Test Systems director reported an open‑market sale of 6,000 shares of common stock on November 5, 2025 at a weighted average price of $25.7262, with individual trades executed between $25.50 and $25.99.
Following the transaction, the reporting person beneficially owned 218,328 shares, held directly. The filing notes that this amount includes shares subject to unvested restricted stock units.
AEHR Test Systems reported an insider transaction on a Form 4. On November 3, 2025, an officer (EVP, PPBI Business) had 203 shares of common stock withheld to cover taxes upon the vesting of restricted stock units, coded F at $25.99 per share. This was a tax withholding event, not a market sale by the insider.
Following the transaction, the insider beneficially owns 77,776 shares. The reported total includes shares subject to unvested restricted stock units.
Aehr Test Systems (AEHR) reported an insider equity transaction by its CTO. On 10/27/2025, 102 shares of common stock were withheld at $25.14 to cover tax obligations upon the vesting of restricted stock units; this was not an open‑market sale by the reporting person.
Following this tax withholding, the reporting person beneficially owned 214,518 shares directly. The reported total includes shares subject to unvested restricted stock units.
Aehr Test Systems executive reported a routine tax-withholding transaction. On 10/27/2025, the VP, Contactor Business Unit had 132 shares withheld at $25.14 per share (code F) to cover taxes upon RSU vesting; this was not an open‑market sale.
Following the transaction, the reporting person beneficially owned 29,228 shares directly and 5,214 shares indirectly through a trust.
Aehr Test Systems (AEHR) President and CEO, also a director, reported a routine Form 4 transaction. On 10/27/2025, 819 shares of common stock were withheld at $25.14 under code “F” to satisfy tax obligations upon RSU vesting; this is not a market sale.
Following the transaction, beneficial ownership stands at 261,095 shares direct and 291,628 shares indirect by trust. The reported amounts include shares subject to unvested restricted stock units and unvested restricted shares.
Aehr Test Systems (AEHR) Chief Operating Officer filed a Form 4 reporting an automatic tax withholding related to RSU vesting. On 10/27/2025, 142 shares of common stock were withheld at $25.14 under transaction code F, which reflects shares withheld to cover taxes and is not a sale by the reporting person. Following the transaction, the officer directly beneficially owned 46,784 shares, which the filing notes include shares subject to unvested RSUs.
AEHR Test Systems reported an insider transaction by its Executive VP of Sales & Marketing. On 10/27/2025, the officer had 197 shares of common stock withheld to satisfy tax obligations upon the vesting of restricted stock units, coded F at $25.14 per share. The filing notes this was a tax withholding and not a sale by the reporting person.
Following the transaction, the officer beneficially owned 178,792 shares directly. The reported total includes shares subject to unvested restricted stock units.
Aehr Test Systems reported an insider transaction by its Exec VP of Sales & Marketing. On 10/22/2025, the officer exercised options and acquired 110,283 and 185 shares of common stock at an exercise price of $2.03 per share (transaction code M).
Following these transactions, the officer reported 178,989 shares beneficially owned, held directly. The exercised options were from grants dated 11/23/2018 with expiration on 10/23/2025, and the remaining derivative balance for these grants is 0. A footnote states the reported amount includes shares subject to unvested restricted stock units.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
